Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Morocco Update

26 Oct 2020 07:00

RNS Number : 1262D
Quadrise Fuels International PLC
26 October 2020
 

26 October 2020

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

COMPLETION OF MOROCCAN PILOT PLANT TRIAL

AND

NEW INDUSTRIAL SCALE TRIAL AT ANOTHER OF THE CLIENT'S SITES IN MOROCCO

 

Quadrise is pleased to provide an update on the Material Transfer & Cooperation Agreement (the "Agreement") with an international chemicals and mining group headquartered in Morocco (the "Client") announced on 29 November 2019.

 

Following the relaxation of Covid-19 restrictions, Quadrise was able to gain access to the Client's facility in October 2020 and is pleased to confirm that the pilot plant trial has now been completed by the combined Quadrise and Client project team.

 

Quadrise and the Client are now working jointly on detailed plans for a larger, industrial-scale MSAR® trial at another Client site, which is planned for early Q1 2021, ahead of the commercial scale phase 2 trials.

 

This new industrial-scale MSAR® trial is intended to further demonstrate the wider potential of MSAR® at another site ahead of the commercial scale trials already being planned under phase 2 of the Agreement. The study work for the Phase 2 trials was brought forward earlier this year and is now well advanced; and, together, with the new industrial scale trial further minimises the risk of delay to the overall programme.

 

Further updates will be provided, as appropriate, in due course.

Mike Kirk, Chairman of QFI, said:

"The major industrial group in Morocco we are working with is a world leader in the sectors in which it operates and is a material consumer of fuel oil. As such, we are delighted to have been able to successfully deliver the MSAR® pilot plant trial under very challenging circumstances which is a testament to the strong rapport and relationships we have built with the Client.

"Feasibility studies are simultaneously being completed under phase 2 as previously reported, that together with the planned industrial scale trials announced today, will demonstrate the wider potential for MSAR® use at the client's sites and more widely in the industrial sector.

"We are therefore confident that during 2021 we will successfully validate the economic and environmental benefits of MSAR® at an industrial scale, complete the commercial scale trials on the Client's units and initiate commercial supply of MSAR® after concluding commercial supply agreements."

 

For further information, please contact:

 

Quadrise Fuels International Plc

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

Joint Brokers

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

David McKeown

Shore Capital Stockbrokers Limited

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

 

Public & Investor Relations

FTI Consulting

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFSAIELEFII
Date   Source Headline
31st Oct 20167:00 amRNSResult of Open Offer
28th Oct 201611:53 amRNSHolding(s) in Company
26th Oct 20164:46 pmRNSHolding(s) in Company & Director/PDMR Shareholding
18th Oct 20167:00 amRNSNew Corporate Website
14th Oct 20167:00 amRNSOpen Offer
12th Oct 20162:46 pmRNSResults of Placing
12th Oct 20167:01 amRNSProposed Placing and Proposed Open Offer
12th Oct 20167:00 amRNSFinal Results
30th Sep 20167:00 amRNSOperational Update
14th Sep 20167:00 amRNSExtension of Contracts with AkzoNobel
11th Aug 20165:20 pmRNSHolding(s) in Company
10th Aug 20168:43 amRNSMemorandum of Understanding
21st Jul 20167:00 amRNSDirectorate Change
12th Jul 20164:24 pmRNSDirector/PDMR Shareholding
5th Jul 20162:05 pmRNSDirector/PDMR Shareholding
5th Jul 20167:00 amRNSEnd of Year Update
28th Jun 20163:09 pmRNSHolding(s) in Company
13th Jun 20164:40 pmRNSSecond Price Monitoring Extn
13th Jun 20164:35 pmRNSPrice Monitoring Extension
10th Jun 20164:40 pmRNSSecond Price Monitoring Extn
10th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Apr 20165:11 pmRNSIssue of Options and Director's Dealing
1st Apr 20167:00 amRNSFurther re Directorate Change
24th Mar 20164:13 pmRNSIssue of Options and Directors' Dealings
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 20163:04 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSHalf Yearly Report
17th Mar 20161:11 pmRNSMarine Programme Update
3rd Mar 20164:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:13 pmRNSNotice of Interim Results
2nd Feb 20167:00 amRNSDirectorate Change
21st Dec 20152:24 pmRNSDirector/PDMR Shareholding
17th Dec 20154:40 pmRNSSecond Price Monitoring Extn
17th Dec 20154:35 pmRNSPrice Monitoring Extension
14th Dec 20152:23 pmRNSFeasibility Study Contract
27th Nov 20154:16 pmRNSResult of AGM
23rd Nov 20157:00 amRNSDirectorate Change
19th Nov 20157:00 amRNSUpdate re Research & Development Programmes
4th Nov 20154:47 pmRNSPosting of Annual Report and Notice of AGM
2nd Nov 20154:35 pmRNSPrice Monitoring Extension
15th Oct 20154:40 pmRNSSecond Price Monitoring Extn
15th Oct 20154:35 pmRNSPrice Monitoring Extension
12th Oct 20157:00 amRNSFinal Results
1st Oct 20155:38 pmRNSHolding(s) in Company
16th Sep 20157:00 amRNSHalf Year Update on Major Active Programmes
25th Aug 20154:41 pmRNSSecond Price Monitoring Extn
25th Aug 20154:35 pmRNSPrice Monitoring Extension
13th Aug 20154:35 pmRNSPrice Monitoring Extension
12th Aug 20154:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.